Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
Open Access
- 21 April 2020
- journal article
- research article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 88, 547-558
- https://doi.org/10.1016/j.bbi.2020.04.039
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Deficiency of Schnurri-2, an MHC Enhancer Binding Protein, Induces Mild Chronic Inflammation in the Brain and Confers Molecular, Neuronal, and Behavioral Phenotypes Related to SchizophreniaNeuropsychopharmacology, 2013
- Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depressionMolecular Psychiatry, 2012
- Psychopathology and the Human Connectome: Toward a Transdiagnostic Model of Risk For Mental IllnessNeuron, 2012
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial OveractivationJournal of Neuroimmune Pharmacology, 2011
- Functional Biomarkers of Depression: Diagnosis, Treatment, and PathophysiologyNeuropsychopharmacology, 2011
- Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised QstatisticsBMC Medical Research Methodology, 2011
- Autoimmune diseases, bipolar disorder, and non‐affective psychosisBipolar Disorders, 2010
- A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophreniaSchizophrenia Research, 2009
- A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorderPsychological Medicine, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003